{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T18:45:01Z","timestamp":1758393901865,"version":"3.44.0"},"reference-count":16,"publisher":"BMJ","funder":[{"name":"National Institutes of Health's National Center for Advancing Translational Sciences"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2017,7,7]]},"abstract":"<jats:p>Pathological variants in genes encoding calmodulin are associated with severe clinical presentations, including recurrent ventricular fibrillation and sudden death. Beta-receptor antagonists (beta-blockers) and sodium-channel antagonists have been reported as pharmacotherapies in these disorders; however, recent data have demonstrated the importance of derangements in calcium channel inactivation. We report a sustained attempt to use calcium-channel antagonists to treat calmodulinopathy and review the treatment strategies reported in the literature to date.<\/jats:p>","DOI":"10.1136\/bcr-2017-220568","type":"journal-article","created":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T10:15:35Z","timestamp":1502100935000},"page":"bcr-2017-220568","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Treatment of calmodulinopathy with verapamil"],"prefix":"10.1136","volume":"2017","author":[{"given":"Gregory","family":"Webster","sequence":"first","affiliation":[{"name":"Division of Cardiology, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary J","family":"Schoppen","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Alfred L","family":"George","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,8,7]]},"reference":[{"key":"2025082804085666000_2017.aug07_1.bcr-2017-220568.1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.001216"},{"key":"2025082804085666000_2017.aug07_1.bcr-2017-220568.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2012.08.015"},{"key":"2025082804085666000_2017.aug07_1.bcr-2017-220568.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2014.10.035"},{"key":"2025082804085666000_2017.aug07_1.bcr-2017-220568.4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/cvr\/cvx006","article-title":"Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes","volume":"113","author":"Rocchetti","year":"2017","journal-title":"Cardiovasc Res"},{"key":"2025082804085666000_2017.aug07_1.bcr-2017-220568.5","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/j.hrthm.2016.06.038","article-title":"Novel calmodulin mutations associated with congenital long QT syndrome affect calcium current in human cardiomyocytes","volume":"13","author":"Pipilas","year":"2016","journal-title":"Heart Rhythm"},{"key":"2025082804085666000_2017.aug07_1.bcr-2017-220568.6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.115.001323"},{"key":"2025082804085666000_2017.aug07_1.bcr-2017-220568.7","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.000996"},{"key":"2025082804085666000_2017.aug07_1.bcr-2017-220568.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2014.04.022"},{"key":"2025082804085666000_2017.aug07_1.bcr-2017-220568.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.113.000459"},{"key":"2025082804085666000_2017.aug07_1.bcr-2017-220568.10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021823"},{"key":"2025082804085666000_2017.aug07_1.bcr-2017-220568.11","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.6.616"},{"key":"2025082804085666000_2017.aug07_1.bcr-2017-220568.12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.676627"},{"key":"2025082804085666000_2017.aug07_1.bcr-2017-220568.13","doi-asserted-by":"publisher","DOI":"10.1038\/nature09855"},{"key":"2025082804085666000_2017.aug07_1.bcr-2017-220568.14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.hrcr.2016.02.002","article-title":"Novel CALM3 mutations in pediatric long QT syndrome patients support a CALM3-specific calmodulinopathy","volume":"2","author":"Chaix","year":"2016","journal-title":"HeartRhythm Case Rep"},{"key":"2025082804085666000_2017.aug07_1.bcr-2017-220568.15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153851","article-title":"Calmodulin 2 mutation N98S is associated with unexplained cardiac arrest in infants due to low clinical Penetrance electrical disorders","volume":"11","author":"Jim\u00e9nez-J\u00e1imez","year":"2016","journal-title":"PLoS One"},{"key":"2025082804085666000_2017.aug07_1.bcr-2017-220568.16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.116.004161"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-220568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T11:09:03Z","timestamp":1756379343000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-220568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,7]]},"references-count":16,"alternative-id":["10.1136\/bcr-2017-220568"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-220568","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2017,8,7]]}}}